NO924151L - Komplekse salter av hematoporfyrin, derivater derav, fremgangsmaate for fremstilling samt terapeutisk anvendelse - Google Patents
Komplekse salter av hematoporfyrin, derivater derav, fremgangsmaate for fremstilling samt terapeutisk anvendelseInfo
- Publication number
- NO924151L NO924151L NO92924151A NO924151A NO924151L NO 924151 L NO924151 L NO 924151L NO 92924151 A NO92924151 A NO 92924151A NO 924151 A NO924151 A NO 924151A NO 924151 L NO924151 L NO 924151L
- Authority
- NO
- Norway
- Prior art keywords
- hematoporphyrine
- derivatives
- procedure
- manufacturing
- therapeutic application
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
- A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
- A61K49/0036—Porphyrins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
- A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
- A61K49/0052—Small organic molecules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PL91292220A PL165249B1 (pl) | 1991-10-29 | 1991-10-29 | Sposób otrzymywania soli kompleksowych hematoporfiryny i jej pochodnych PL PL PL PL PL PL PL |
Publications (3)
Publication Number | Publication Date |
---|---|
NO924151D0 NO924151D0 (no) | 1992-10-28 |
NO924151L true NO924151L (no) | 1993-04-30 |
NO300499B1 NO300499B1 (no) | 1997-06-09 |
Family
ID=20055985
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO924151A NO300499B1 (no) | 1991-10-29 | 1992-10-28 | Komplekse salter av hematoporfyrin og av derivater derav, blandinger av slike salter samt terapeutisk middel for detektering og/eller behandling av neoplasmer |
Country Status (18)
Country | Link |
---|---|
US (1) | US5451599A (no) |
EP (1) | EP0539960B1 (no) |
JP (1) | JP3020759B2 (no) |
CN (1) | CN1040328C (no) |
BG (1) | BG61648B1 (no) |
CA (1) | CA2081605C (no) |
CZ (1) | CZ281694B6 (no) |
DE (1) | DE69217819T2 (no) |
DK (1) | DK0539960T3 (no) |
FI (1) | FI100243B (no) |
HR (1) | HRP921337B1 (no) |
LV (1) | LV11952B (no) |
NO (1) | NO300499B1 (no) |
PL (1) | PL165249B1 (no) |
RU (1) | RU2122003C1 (no) |
SI (1) | SI9200286B (no) |
UA (1) | UA40568C2 (no) |
YU (1) | YU48961B (no) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5876989A (en) * | 1994-09-08 | 1999-03-02 | Photocure As | Transfer of molecules into the cytosol of cells |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5948771A (en) * | 1996-01-31 | 1999-09-07 | The Trustees Of Columbia University In The City Of New York | Method for treating heart failure using tetrapyrroles and metallotetrapyrroles |
GB9606293D0 (en) * | 1996-03-26 | 1996-05-29 | William Harvey Research Limite | Treatment of cancers and other tumours |
AU2085302A (en) | 2000-11-29 | 2002-06-11 | Norwegian Radium Hospital Res | Photochemical internalization for delivery of molecules into the cytosol |
CN100490902C (zh) | 2000-11-29 | 2009-05-27 | Pci生物技术联合股份有限公司 | 病毒介导的分子传递进入胞质溶胶的光化学内在化 |
CN104130266A (zh) * | 2013-05-02 | 2014-11-05 | 中国医学科学院生物医学工程研究所 | 一种新型原卟啉衍生物及制备方法 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2912M (fr) * | 1963-07-24 | 1964-11-09 | Rech S Pharma E R P H A R Soc | Dichlorhydrate d'hématoporphyrinate de procaine. |
KR910009202B1 (ko) * | 1985-10-23 | 1991-11-04 | 니혼메디피직스 가부시끼가이샤 | 포르피린 유도체의 제조방법 |
US4882234A (en) * | 1986-11-12 | 1989-11-21 | Healux, Inc. | Storage-stable porphin compositions and a method for their manufacture |
US5190966A (en) * | 1988-07-06 | 1993-03-02 | Health Research, Inc. | Purified hematoporphyrin dimers and trimers useful in photodynamic therapy |
US4968715A (en) * | 1988-07-06 | 1990-11-06 | Health Research, Inc. | Use of purified hematoporphyrin trimers in photodynamic therapy |
US4961920A (en) * | 1988-12-08 | 1990-10-09 | Luminis Pty, Ltd. | Phototherapeutic monovinyl and divinyl ether-linked dimers |
CN102565846B (zh) * | 2011-12-30 | 2014-05-14 | 清华大学 | 蜂窝型热中子探测器 |
-
1991
- 1991-10-29 PL PL91292220A patent/PL165249B1/pl not_active IP Right Cessation
-
1992
- 1992-10-26 FI FI924856A patent/FI100243B/fi not_active IP Right Cessation
- 1992-10-28 EP EP92118447A patent/EP0539960B1/en not_active Expired - Lifetime
- 1992-10-28 DK DK92118447.9T patent/DK0539960T3/da active
- 1992-10-28 NO NO924151A patent/NO300499B1/no not_active IP Right Cessation
- 1992-10-28 BG BG97030A patent/BG61648B1/bg unknown
- 1992-10-28 RU RU92004314/04A patent/RU2122003C1/ru not_active IP Right Cessation
- 1992-10-28 DE DE69217819T patent/DE69217819T2/de not_active Expired - Lifetime
- 1992-10-28 CA CA002081605A patent/CA2081605C/en not_active Expired - Lifetime
- 1992-10-29 US US07/968,434 patent/US5451599A/en not_active Expired - Lifetime
- 1992-10-29 YU YU94592A patent/YU48961B/sh unknown
- 1992-10-29 JP JP4291322A patent/JP3020759B2/ja not_active Expired - Lifetime
- 1992-10-29 SI SI9200286A patent/SI9200286B/sl not_active IP Right Cessation
- 1992-10-29 CN CN92112561A patent/CN1040328C/zh not_active Expired - Fee Related
- 1992-10-29 CZ CS923252A patent/CZ281694B6/cs not_active IP Right Cessation
- 1992-11-24 HR HRP-945A patent/HRP921337B1/xx not_active IP Right Cessation
-
1993
- 1993-06-15 UA UA93002921A patent/UA40568C2/uk unknown
-
1997
- 1997-06-05 LV LVP-97-110A patent/LV11952B/en unknown
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5876989A (en) * | 1994-09-08 | 1999-03-02 | Photocure As | Transfer of molecules into the cytosol of cells |
US6680301B2 (en) | 1994-09-08 | 2004-01-20 | Photocure As | Transfer of molecules into the cytosol of cells |
Also Published As
Publication number | Publication date |
---|---|
LV11952A (lv) | 1998-01-20 |
EP0539960B1 (en) | 1997-03-05 |
CA2081605C (en) | 2002-02-26 |
HRP921337A2 (en) | 1994-10-31 |
US5451599A (en) | 1995-09-19 |
CA2081605A1 (en) | 1993-04-30 |
CN1071914A (zh) | 1993-05-12 |
BG61648B1 (bg) | 1998-02-27 |
DK0539960T3 (da) | 1997-09-15 |
BG97030A (bg) | 1994-03-24 |
DE69217819T2 (de) | 1997-09-04 |
JPH05262775A (ja) | 1993-10-12 |
YU48961B (sh) | 2003-01-31 |
CZ281694B6 (cs) | 1996-12-11 |
SI9200286B (en) | 2001-06-30 |
EP0539960A2 (en) | 1993-05-05 |
CN1040328C (zh) | 1998-10-21 |
CZ325292A3 (en) | 1993-09-15 |
FI924856A (fi) | 1993-04-30 |
HRP921337B1 (en) | 2000-02-29 |
FI100243B (fi) | 1997-10-31 |
LV11952B (en) | 1998-06-20 |
NO300499B1 (no) | 1997-06-09 |
UA40568C2 (uk) | 2001-08-15 |
RU2122003C1 (ru) | 1998-11-20 |
PL292220A1 (en) | 1993-09-20 |
JP3020759B2 (ja) | 2000-03-15 |
SI9200286A (en) | 1993-06-30 |
NO924151D0 (no) | 1992-10-28 |
DE69217819D1 (de) | 1997-04-10 |
PL165249B1 (pl) | 1994-11-30 |
FI924856A0 (fi) | 1992-10-26 |
EP0539960A3 (en) | 1993-06-16 |
YU94592A (sh) | 1995-12-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO172801C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive kinuklidin-derivater | |
NO914667L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive arylderivater | |
NO904694L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive imidazolderivater. | |
NO914036L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive kinazolin-derivater | |
NO901684D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive 3-substituerte-2-oksindol-derivater. | |
NO895087D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive cykliske eter-derivater. | |
NO172240C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive nye 2'-halometylidenderivater | |
NO171412C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,3-oksatiolan- eller 1,3-ditiolanderivater | |
NO171856C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive adenosinderivater | |
NO893909L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive imidazol-derivater. | |
NO171857C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 2'-halomethyliden-adenosin-derivater | |
NO891723D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive kinazolin-derivater. | |
NO173061C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-benzotiazoliner | |
NO924151L (no) | Komplekse salter av hematoporfyrin, derivater derav, fremgangsmaate for fremstilling samt terapeutisk anvendelse | |
NO169648C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive arakidonsyre-derivater | |
NO172802C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive tienopyraner | |
NO890607L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive pyridin-derivater. | |
NO900972L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive naftalen-derivater. | |
NO940131D0 (no) | Salter av 4-pyrimidinon-derivater for framasoeytisk anvendelse | |
NO169589C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive tetraazaacenaftylen-derivater | |
NO900942D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive azacyklooktadien-derivater. | |
NO168587C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazodiazepin-derivater | |
NO890519D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive propanon-derivater. | |
NO169486C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive allylaminoetylazoler | |
NO170541C (no) | Analogiframgangsmaate for framstilling av terapeutisk aktive 1,5-benzotiazepinderivater |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM1K | Lapsed by not paying the annual fees |